Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02378467 · ClinicalTrials.gov registry record · NA
Saline Hypertonic in Preschoolers
A NA study of Cystic Fibrosis, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 20
- Study locations
NCT02378467 is a NA study of Cystic Fibrosis that has completed, run by University of Washington, the Collaborative Health Studies Coordinating Center. The registered enrollment target is 150 participants, below the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (16% lower). The trial reports 20 study locations across 16 states.
The verdict
NCT02378467, a NA study of Cystic Fibrosis, has completed, sponsored by University of Washington, the Collaborative Health Studies Coordinating Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to assess whether inhalation of 7% hypertonic saline (HS) twice daily for 48 weeks improves the lung clearance index by multiple breath nitrogen washout in comparison with inhalation of 0.9% isotonic saline (IS) in preschool children (ages 3 to 5) with cystic fibrosis.
Conditions Studied
Interventions
- DRUG 7% Hypertonic Saline (HS)
- DRUG 0.9% Isotonic Saline (IS)
Study Locations (20)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Rainbow Babies Children's Hospital and Case Western Reserve University School of Medicine - Cleveland
- Nationwide Children's Hospital - Columbus
Missouri
- Children's Mercy Hospital - Kansas City
- Washington University School of Medicine - St Louis
Pennsylvania
- Children's Hospital of Philadelphia, UPenn - Philadelphia
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
Alabama
- University of Alabama-Birmingham: Pulmonary, Allergy and Critical Care Medicine - Birmingham
California
- Stanford University - Palo Alto
Colorado
- Children's Hospital of Colorado - Aurora
Florida
- Nemours Children's Hospital - Orlando
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2015-03-01 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
Sponsor
University of Washington, the Collaborative Health Studies Coordinating Center5 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02378467
The ClinicalTrials.gov registry entry for NCT02378467 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (16% lower). The listed sponsor is University of Washington, the Collaborative Health Studies Coordinating Center, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 2 interventions - of which 7% Hypertonic Saline (HS) is the first listed.
NCT02378467 reports 20 study locations spanning 16 distinct geographic areas - top geographies include Ohio, Missouri, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02378467 about?
NCT02378467 is a clinical study titled "Saline Hypertonic in Preschoolers". The purpose of this study is to assess whether inhalation of 7% hypertonic saline (HS) twice daily for 48 weeks improves the lung clearance index by multiple breath nitrogen washout in comparison with inhalation of 0.9% isotonic saline (IS) in preschool children (ages 3 to 5) with cystic fibrosis.
What is the current status of trial NCT02378467?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2015-03-01. Estimated completion is 2018-08-31.
What conditions does trial NCT02378467 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT02378467?
The interventions under investigation include: 7% Hypertonic Saline (HS) (DRUG), 0.9% Isotonic Saline (IS) (DRUG).
Who is sponsoring clinical trial NCT02378467?
This trial is sponsored by University of Washington, the Collaborative Health Studies Coordinating Center, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02378467 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
FEED-Cystic Fibrosis (FEED-CF)
RECRUITING · NA
-
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
RECRUITING · NA
-
Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
RECRUITING · NA
-
Lung Transplant READY CF 2: CARING CF Ancillary RCT
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.